Table 4 Summary of published literatures on perioperative outcomes and complications of AIS surgery
Paper | Year | Single/ Multi | N | Approach | Operation Time (mins) | Blood Loss (ml) | Length of Stay (days) | Allogeneic Blood Transfusion | Complication Rate | Mortality | Neurologic Deficit | Infection | Respiratory | DVT/PE |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Present paper |  2021 | S | 1057 | PSF | 146.8 ± 49.4 | 952.9 ± 530.4 | 3.5 ± 0.9 | 53 (5) |  24 (2.27) | 0 | 5 (0.47) | 14 (1.32) | 1 (0.09) | 0 |
Koo et al. [36] | 2020 | M | 3759 | PSF | NA | NA | 5.16 ± 2.8 | 721(19.2) | 864 (23.0) | NS | NS | 51 (1.7) | 60 (1.6) | 0 |
Vavruch et al. [37] | 2019 | M | 27 | PSF | 255 ± 48 | 1615 ± 901 | 8 ± 1.3 | NA | 7 (25.9) | 0 | NS | 2 (7.4) | 0 | NS |
Bartley et al. [28] | 2017 | M | 3582 | ASF, PSF and APSF | NA | NA | NA | NA | 93 (2.6) | 1 (0.03) | 19 (0.53) | 20 (0.56) | 13 (0.36) | 0 |
Menger et al. [12] | 2017 | M | 75,106 | NS | NA | NA | 5.72 | NA | 6451 (8.59) | 69 (0.1) | 648 (0.9) | 496 (0.4) | 2068 (2.8) | 73 (0.1) |
Sugawara et al. [10] | 2017 | M | 458 | NS | NA | NA | NA | NA | 37 (8.08) | 0 | 12 (2.62) | 11 (2.4) | 1 (0.22) | 1 (0.22) |
de Bodman et al. [38] | 2017 | S | 70 | MIS PSF | 337.1 ± 121.3 | 345.7 ± 175.1 | 4.6 ± 0.8 | 0 | 8 (11.4) | 0 | 0 | 4 (5.7) | 1 (1.4) | 1 (1.4) |
Chiu et al. [39] | 2016 | S | 100 | PSF | 188.5 ± 53.4 | 951 ± 454 | 3.5 ± 0.9 | NA | NA | NA | NA | NA | NA | NA |
Vigneswaran et al. [16] | 2015 | M | 1783–5228 | ASF, PSF and APSF | NA | NA | 5.6 ± 5.7 – 6.6 ± 6.2 | NA | 279 (15.65)– 1167 (22.32) | 1 (0.02) – 4 (0.22) | < 1% | 43 (2.4) – 89 (1.7) | < 1% | < 1% |
Vigneswaran et al. [16] | 2015 | M | 1130–4917 | PSF only | NA | NA | 5.4 ± 5–5.9 ± 4.2 | NA | 164 (14.5) – 1010 (27.3) | 9 (0.06) | < 1% | 50 (4.4) – 98 (2) | < 1% | < 1% |
Basques et al. [33] | 2015 | M | 733 | PSF | > 365 mins in 108 (14.7%) | NA | > 6 days in 60 (8.2%) | NA | 27 (3.7) | 0 | 3 (0.4) | 15 (2.0) | 1 (0.1) | 0 |
Imajo et al. [40] | 2015 | M | 1485 | ASF, PSF and APSF | NA | NA | NA | NA | 245 (16.5) | 1 (0.07) | 31 (2.1) | NS | NS | NS |
Tarrant et al. [14] | 2014 | M | 77 | PSF | 330.0a (258.0–420.0) | 1012 (791–1400) | 10a (8–11) | 36 (46.8) | 4 (5.2) | 0 | NA | 5 (6.5) | 19 (24.68) | 0 |
Cristante et al. [35] | 2014 | S | 94 | PSF | 329.99 (307.95–358.02) | NA | NA | 43 (47.7) | NA | NA | NA | NA | NA | NA |
Roberts at al [13] | 2014 | S | 72 | PSF | 139.0 (108–190) | 419 (180–750) | 6.1 (5–8) | NA | 1 (1.4) | 0 | 1 (1.4) | 0 | 0 | 0 |
Divecha et al. [18] | 2014 | M | 9295 | NS | NA | NA | NA | NA | 339 (3.64) | 17 (0.19) | 100 (1.1) | 222 (2.4) | NA | NA |
Yilmaz et al. [25] | 2012 | S | 35 | PSF | 351.5 ± 73.2 | 1211.7 ± 643.7 | NA | NA | 1 (2.85) | NA | 0 | 1 (2.85) | 0 | 0 |
Fu et al. [31] | 2011 | M | 23,918 | NS | NA | NA | NA | NA | 2040 (8.5) | 31 (0.13) | 324 (1.4) | 661 (2.7) | 224 (0.9) | 17 (0.07) |
Reames et al. [2] | 2011 | M | 11,227 | NS | NA | NA | NA | NA | 760 (6.3) | 2 (0.02) | 86 (0.8) | 156 (1.4) | 63 (0.6) | 6 (0.05) |
Hod-Feins et al. [9] | 2007 | S | 95 | ASF, PSF and APSF | 402 | NA | 3.23 | NA | NA | 0 | 2 (2.1) | 0 | 5 (5.2) | 0 |
Carreon et al. [4] | 2007 | M | 702 | ASF, PSF and APSF | NA | NA | NA | NA | 108 (15.4) | 0 | NS | 5 (0.71) | 13 (1.85) | 0 |
Coe et al. [11] | 2006 | M | 4369 | PSF | NA | NA | NA | NA | 221 (5.05) | 2 (0.05) | 14 (0.32) | 59 (1.35) | 42 (0.96) | 3 (0.07) |